Ticker Scorecard - RCUS Basics Company: Arcus Biosciences, Inc. IPO Date: March 12, 2018 Sector: Healthcare Industry: Biotech Market Cap: $1.16B Activated in VL: True Average Daily Range Avg Daily Range: $0.61 | 3.00% Avg Daily Range (30 D): $0.34 | 2.56% Avg Daily Range (90 D): $0.39 | 2.59% Institutional Daily Volume Avg Daily Volume: .49M Avg Daily Volume (30 D): .69M Avg Daily Volume (90 D): .64M Trade Size Avg Trade Size (Sh.): 78 Avg Trade Size (Sh.) (30 D): 82 Avg Trade Size (Sh.) (90 D): 79 Institutional Trades Total Inst.Trades: 2,344 Avg Inst. Trade: $2.39M Avg Inst. Trade (30 D): $2.13M Avg Inst. Trade (90 D): $1.72M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.94M Avg Closing Trade (30 D): $2.26M Avg Closing Trade (90 D): $1.92M Avg Closing Volume: 130.04K     News Dec 2, 2024 @ 3:18 PM Biotech Advances Drive Cancer Research as Global R... Source: Prnewswire Aug 23, 2024 @ 3:47 PM Retinoblastoma Treatment Market to Surpass $2 Bill... Source: Researchandmarkets.Com Jul 8, 2024 @ 9:00 PM Cracking The Code: Understanding Analyst Reviews F... Source: Benzinga Insights, Benzinga Staff Writer Jun 7, 2024 @ 2:55 PM Is The Options Market Predicting a Spike In Arcus ... Source: Zacks Equity Research Jun 3, 2024 @ 5:59 PM Gilead (GILD), RCUS Announce Data From Colorectal ... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-3.17 $-1 $-1.02 Diluted EPS $-3.17 $-1 $-1.02 Revenue $ 263M $ 48M $ 39M Gross Profit $ $ $ Net Income / Loss $ -270M $ -92M $ -93M Operating Income / Loss $ -318M $ -105M $ -106M Cost of Revenue $ $ $ Net Cash Flow $ 17M $ 45M $ -29M PE Ratio